CAM
ELEV
Cormorant Asset Management’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,952,032
| Closed | -$3.71M | – | 66 |
|
|
2023
Q1 | $3.71M | Hold |
1,952,032
| – | – | 0.24% | 53 |
|
|
2022
Q4 | $1.85M | Hold |
1,952,032
| – | – | 0.12% | 59 |
|
|
2022
Q3 | $2.21M | Sell |
1,952,032
-31,136
| -2% | -$35.2K | 0.15% | 58 |
|
|
2022
Q2 | $2.78M | Buy |
1,983,168
+3
| +0% | +$4 | 0.21% | 58 |
|
|
2022
Q1 | $5M | Hold |
1,983,165
| – | – | 0.38% | 52 |
|
|
2021
Q4 | $11.9M | Hold |
1,983,165
| – | – | 0.71% | 38 |
|
|
2021
Q3 | $15.1M | Hold |
1,983,165
| – | – | 0.62% | 42 |
|
|
2021
Q2 | $25.6M | Buy |
+1,983,165
| New | +$25.6M | 0.87% | 29 |
|